HER-2 B cell epitope peptide-based cancer vaccines and combination immunotherapies with EGFR, HER-3, IGF-1R, VEGF and a therapeutic combination vaccine of PD-1 and HER-2

09/05/2018 15:00h.

Lloc: Sala Marie Curie

Tipus d'activitat: Sessions científiques

Ponents: Pravin T. P. Kaumaya

Organitzador: Departament CEXS, UPF

Tornar

Documents: